DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis..
PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Lancet 1998;
352: 1498-504.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.